Leaderboard

En | De
Sie sind hier: Gastroenterologie » Pankreas » Neoplasie 14. Juli 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3041  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 60819  
   
Implications and risk of new versus persisting intraductal papillary mucinous neoplasms after pancreatic surgery: meta-analysis.
BJS Open
van Bodegraven AJ, Marstaller-Walz KM, Padoan V, Heo D, Perri G, Burchell GL, Loos M, Michalski CW, Besselink MG, Cillo U, Rompen IF, Marchegiani G.
PMID: 42441942 [PubMed - in process]


Baseline and dynamic neutrophil-to-lymphocyte ratio predicts overall survival in unresectable pancreatic cancer following dose-escalated SBRT: a ten-year longitudinal study.
Front Mol Biosci
Di Y, Sun Z, Song Z, Meng L.
PMID: 42440477 [PubMed]


Primary pancreatic paraganglioma: a systematic review.
Endocrine
Guerrero-Pérez F, Sánchez-Barrera R, Quiñonero Góngora P, Serrano T, Busquets J, Secanella L, Vercher-Conejero JL, Iglesias P.
PMID: 42440163 [PubMed - indexed for MEDLINE]


Preoperative predictors of early recurrence after neoadjuvant gemcitabine plus S-1 in resectable pancreatic cancer: a multicenter study.
Surg Today
Shirai Y, Hamura R, Tsunematsu M, Gocho T, Sakamoto T, Onda S, Tanji Y, Okui N, Matsumoto M, Furukawa K, Haruki K, Ikegami T.
PMID: 42439926 [PubMed - as supplied by publisher]


Surveillance for Pancreatic Cancer: Knowledge, Motivations, Barriers, and Preferences Among High-Risk Individuals and Underserved Populations.
Cancer Control
Houweling EV, McCoy S, Sheppard B, Guimaraes AR, Sears R, Shannon J, Farris PE, Jäderholm CM, Coté GA.
PMID: 42439864 [PubMed - indexed for MEDLINE]


Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology.
J Hepatocell Carcinoma
Cao W, Fan Y, Chen H, Sun J, Jin X.
PMID: 42438783 [PubMed]


Neoantigens in Cancer Immunotherapy: An Overview with a Focus on Non-small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma.
Iran J Allergy Asthma Immunol
Eskandari-Malayeri F, Shekarchian S, Mortaz E.
PMID: 42437308 [PubMed - indexed for MEDLINE]


Assessing collagenase-a and type-II mediated degradation of human type-I collagen by photoacoustic spectroscopy toward clinical translation in cancer progression.
Sci Rep
Biswas S, Chandra S, Bhat G, Mathew S, Murali TS, Mahato KK.
PMID: 42436335 [PubMed - as supplied by publisher]


Hydrogel-based platforms for localized cancer treatment: Design strategies for precision therapeutic delivery.
J Control Release
Salathia S, Casadidio C, Censi R.
PMID: 42435859 [PubMed - as supplied by publisher]


Periodic surveillance of intraductal papillary mucinous neoplasms: gaps in evidence and future directions.
J Natl Cancer Inst
Hamada T, Oyama H, Nakai Y, Petrov MS.
PMID: 42435394 [PubMed - as supplied by publisher]


Prognostic value of lactate dehydrogenase-to-albumin ratio in metastatic/recurrent pancreatic cancer treated with first-line gemcitabine plus nab-paclitaxel: a single-center retrospective cohort study.
J Gastrointest Oncol
Yamauchi Y, Sofuni A, Nagakawa Y, Itoi T.
PMID: 42434227 [PubMed]


From pancreatic ductal adenocarcinoma to non-small cell lung cancer: daraxonrasib in the RASolute 302 trial - a pan-RAS(ON) breakthrough or the next evolution in targeting diverse oncogenic RAS variants?
Ann Med Surg (Lond)
Qaseem M, Ali MS, Ali S, Hasan AH.
PMID: 42433811 [PubMed]


Dietary fatty acid intake and the risk of pancreatic cancer: a dose-response meta-analysis of observational studies.
Ann Med Surg (Lond)
Al Masri MK, Hasan MK, Ali SA, Alsubaiei AA, Ali SA, AlMaazmi AM, Saleh SAK, Adly HM, Kutbi E, AlJurayyan AN, Abu-Zaid A.
PMID: 42433782 [PubMed]


Real-World Efficacy and Safety of TACE Combined with Lenvatinib and PD-1 Inhibitor in Conversion Therapy for Unresectable Hepatocellular Carcinoma (GUIDANCE007): A Multicenter Retrospective Study.
Liver Cancer
Ye L, Liu GX, Yang DL, Zeng FJ, Liu J, Yao HB, Nong JL, Liu SP, Peng N, Li WF, Wu PS, Qin C, Su Z, Ou JJ, Dong XF, Yan YH, Zhong TM, Wu MS, Chen YZ, Wang GD, Li MJ, Wang XY, Yang FQ, Chen SC, Yang YY, Chen K, Lai YC, Pang QQ, Liang XM, Mao XS, Liang YR, Li FX, Shi H, Li RJ, Xiang BD, Ma L, Zhong JH, Yu YQ, GUIDANCE investigators.
PMID: 42433265 [PubMed - as supplied by publisher]


Impact of Stent Type on Surgical Outcomes in Pancreatic Cancer Patients Undergoing Preoperative Biliary Drainage.
Dig Endosc
Tamura T, Matsumori T, Nishikawa Y, Kitagawa K, Nagai M, Shimizu A, Matsumoto I, Masuda A, Sakai A, Yamai T, Tomokuni A, Ikeura T, Ito T, Doi T, Miyake H, Maruyama H, Ishikawa-Kakiya Y, Ogura T, Ueno S, Shiomi H, Tsujimoto A, Shintani S, Ikeda T, Uenoyama Y, Emori T, Shimatani M, Hanada K, Kitano M, Takenaka M.
PMID: 42433174 [PubMed - indexed for MEDLINE]


Rectal Adenocarcinoma With Enteroblastic Differentiation and Hepatic Metastases: A Rare and Aggressive Variant of Colorectal Carcinoma.
Am J Case Rep
Syed FF, Khalid A.
PMID: 42432994 [PubMed - indexed for MEDLINE]


Solid serous adenoma of the pancreas mimicking a solid pseudopapillary neoplasm: A case report.
Medicine (Baltimore)
Jin S, Lee J, Cho BS, Yi KS, Kim Y, Choi CH, Woo CG.
PMID: 42432909 [PubMed - indexed for MEDLINE]


Redox-senescence function of PON1 in hepatocellular carcinoma and its non-invasive assessment using super-resolution radiomics: a multi-center study.
J Transl Med
Cai C, Hao Y, Xue Y, Li D, Wang Y, Yue X, Hou J, Wang Z, Li BY, Xie M, Zhuang H, Li D, Ding X.
PMID: 42432749 [PubMed - as supplied by publisher]


Factors contributing to the missed diagnosis of incidental gallbladder cancer (IGBC): an integrated analysis of clinical features and ultrasound radiomics.
BMC Cancer
Pan Z, Sun X, Shen Z, Cen F, Yan Q.
PMID: 42432566 [PubMed - as supplied by publisher]


Identification of therapeutic targets and postoperative recurrence prediction model construction for hepatocellular carcinoma based on systematic mendelian randomization.
Arab J Gastroenterol
Kong Y, Wang Y, Yang Q, Ye S.
PMID: 42431780 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 60819    Seite 1 von 3041  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1